Skip to main content
main-content
Erschienen in: Der Urologe 10/2016

29.08.2016 | Chronische Niereninsuffizienz | Evidenzbasierte Medizin

Aldosteron-Antagonisten zur Prävention des Fortschreitens der chronischen Niereninsuffizienz

verfasst von: Dr. S. Schmidt, Dr. A. Spek

Erschienen in: Die Urologie | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Auszug

Bolignano D, Palmer SC, Navaneethan SD, Strippoli GFM (2014) Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews (4): (Art. No.: CD007004) …
Literatur
1.
Zurück zum Zitat Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305 CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305 CrossRefPubMed
3.
Zurück zum Zitat Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298(17):2038–2047 CrossRefPubMed Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298(17):2038–2047 CrossRefPubMed
4.
Zurück zum Zitat Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW et al (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330(13):877–884 CrossRefPubMed Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW et al (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330(13):877–884 CrossRefPubMed
5.
6.
Zurück zum Zitat Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345(12):861–869 CrossRefPubMed Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345(12):861–869 CrossRefPubMed
7.
Zurück zum Zitat Mathiesen ER, Hommel E, Hansen HP, Smidt UM, Parving HH (1999) Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ 319(7201):24–25 CrossRefPubMedPubMedCentral Mathiesen ER, Hommel E, Hansen HP, Smidt UM, Parving HH (1999) Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ 319(7201):24–25 CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G et al (2001) Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135(2):73–87 CrossRefPubMed Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G et al (2001) Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135(2):73–87 CrossRefPubMed
9.
Zurück zum Zitat Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC (2006) Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev 4:Cd006257 PubMed Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC (2006) Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev 4:Cd006257 PubMed
10.
Zurück zum Zitat Fritsch Neves M, Schiffrin EL (2003) Aldosterone: a risk factor for vascular disease. Curr Hypertens Rep 5(1):59–65 CrossRefPubMed Fritsch Neves M, Schiffrin EL (2003) Aldosterone: a risk factor for vascular disease. Curr Hypertens Rep 5(1):59–65 CrossRefPubMed
Metadaten
Titel
Aldosteron-Antagonisten zur Prävention des Fortschreitens der chronischen Niereninsuffizienz
verfasst von
Dr. S. Schmidt
Dr. A. Spek
Publikationsdatum
29.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Die Urologie / Ausgabe 10/2016
Print ISSN: 2731-7064
Elektronische ISSN: 2731-7072
DOI
https://doi.org/10.1007/s00120-016-0215-1

Weitere Artikel der Ausgabe 10/2016

Der Urologe 10/2016 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Urologie und bleiben Sie gut informiert – ganz bequem per eMail.